“…Because enhanced mortality likely results from toxin produced during vegetative growth in infected larvae, it stands to reason that Vip3Aa will play a role primarily in species that die from septicaemia following B. thuringiensis spore germination. Such is the case in many species (e.g., Donovan et al, 2001;van Frankenhuyzen, 1994;Miyasono et al, 1994;Burgess et al, 1976;Johnson and MacGaughey, 1996), but certainly not in all (Nishiitsutusji-Uwo and Endo, 1980;Schesser and Bulla, 1978;Suzuki et al, 2004). Reduced toxicity of the Vip3Aa-producing HD-1 strain to gypsy moth larvae suggests that the contribution of the toxin to pathogenicity could be even more complex in that species.…”
“…Because enhanced mortality likely results from toxin produced during vegetative growth in infected larvae, it stands to reason that Vip3Aa will play a role primarily in species that die from septicaemia following B. thuringiensis spore germination. Such is the case in many species (e.g., Donovan et al, 2001;van Frankenhuyzen, 1994;Miyasono et al, 1994;Burgess et al, 1976;Johnson and MacGaughey, 1996), but certainly not in all (Nishiitsutusji-Uwo and Endo, 1980;Schesser and Bulla, 1978;Suzuki et al, 2004). Reduced toxicity of the Vip3Aa-producing HD-1 strain to gypsy moth larvae suggests that the contribution of the toxin to pathogenicity could be even more complex in that species.…”
“…In other words, extremely high spore density will inhibit crystal protein formation and is not a guarantee of mortality. However, the fact that the presence of spores increased the toxin activity in some Lepi- dopterous larvae has been mentioned (Miyasono et al, 1994). This indirectly demonstrated that the existence of spores in the crystal protein mixture exhibits an enhancement of toxin activity effects.…”
“…Although no evidence exists that spores contribute to the toxicity of B. thuringiensis subsp. israelensis to mosquitoes, it is known that against some species, such as Spodoptera exigua (45) and P. xylostella (46), the spore can synergize Cry toxicity. Despite these obstacles to precise characterization of CytA͞ CryIV interaction, the data from the experiments where the CytA powder was combined with the powders of CryIVA and CryIVB, or CryIVA, CryIVB, and CryIVD, show clearly CytA was the critical component enabling these proteins to suppress or reduce substantially CryIV resistance (Fig.…”
Cry proteins produced by Bacillus thuringiensis are selective biodegradable insecticides used increasingly in bacterial insecticides and transgenic plants as alternatives to synthetic chemical insecticides. However, the potential for development of resistance and cross-resistance in target insect populations to Cry proteins used alone or in combination threatens the more widespread use of this novel pest control technology. Here we show that high levels of resistance to CryIV proteins in larvae of the mosquito, Culex quinquefasciatus, can be suppressed or reduced markedly by combining these proteins with sublethal quantities of CytA, a cytolytic endotoxin of B. thuringiensis. Resistance at the LC 95 level of 127-fold for a combination of three CryIV toxins (CryIVA, B, and D), resulting from 60 generations of continuous selection, was completely suppressed by combining sporulated powders of CytA in a 1:3 ratio with sporulated powders of a CryIVA, CryIVB, and CryIVD strain. Combining the CytA strain with a CryIVA and CryIVB strain also completely suppressed mosquito resistance of 217-fold to the latter toxins at the LC 95 level, whereas combination of CytA with CryIVD reduced resistance in a CryIVD-selected mosquito strain from greater than 1,000-fold to less than 8-fold. The CytA͞CryIV model provides a potential molecular genetic strategy for engineering resistance management for Cry proteins directly into bacterial insecticides and transgenic plants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.